Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats

Exp Physiol. 2007 Mar;92(2):409-16. doi: 10.1113/expphysiol.2006.036590. Epub 2006 Dec 21.

Abstract

It is unclear whether cardiac hypertrophy and hypertrophy-related pathways will be induced by long-term intermittent hypoxia. Thirty-six Sprague-Dawley rats were randomly assigned into three groups: normoxia, and long-term intermittent hypoxia (12% O(2), 8 h per day) for 4 weeks (4WLTIH) or for 8 weeks (8WLTIH). Myocardial morphology, trophic factors and signalling pathways in the three groups were determined by heart weight index, histological analysis, Western blotting and reverse transcriptase-polymerase chain reaction from the excised left ventricle. The ratio of whole heart weight to body weight, the ratio of left ventricular weight to body weight, the gross vertical cross-section of the heart and myocardial morphological changes were increased in the 4WLTIH group and were further augmented in the 8WLTIH group. In the 4WLTIH group, tumour necrosis factor-alpha(TNFalpha), insulin-like growth factor (IGF)-II, phosphorylated p38 mitogen-activated protein kinase (P38), signal transducers and activators of transcription (STAT)-1 and STAT-3 were significantly increased in the cardiac tissues. However, in the 8WLTIH group, in addition to the above factors, interleukin-6, mitogen-activated protein kinase (MEK)5 and extracellular signal-regulated kinase (ERK)5 were significantly increased compared with the normoxia group. We conclude that cardiac hypertrophy associated with TNFalpha and IGF-II was induced by intermittent hypoxia. The longer duration of intermittent hypoxia further activated the eccentric hypertrophy-related pathway, as well as the interleukin 6-related MEK5-ERK5 and STAT-3 pathways, which could result in the development of cardiac dilatation and pathology.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cardiomegaly / etiology
  • Cardiomegaly / genetics
  • Cardiomegaly / metabolism*
  • Cardiomegaly / pathology
  • Disease Models, Animal
  • Gene Expression
  • Hypoxia / complications*
  • Hypoxia / metabolism
  • Insulin-Like Growth Factor II / biosynthesis
  • Intercellular Signaling Peptides and Proteins / biosynthesis*
  • Intercellular Signaling Peptides and Proteins / genetics
  • Interleukin-6 / biosynthesis
  • MAP Kinase Kinase 5 / biosynthesis
  • MAP Kinase Signaling System*
  • Male
  • Mitogen-Activated Protein Kinase 7 / biosynthesis
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Organ Size
  • Phosphorylation
  • RNA, Messenger / metabolism
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction
  • STAT1 Transcription Factor / biosynthesis
  • STAT3 Transcription Factor / biosynthesis
  • Time Factors
  • Tumor Necrosis Factor-alpha / biosynthesis
  • p38 Mitogen-Activated Protein Kinases / biosynthesis

Substances

  • Intercellular Signaling Peptides and Proteins
  • Interleukin-6
  • RNA, Messenger
  • STAT1 Transcription Factor
  • STAT3 Transcription Factor
  • Stat1 protein, rat
  • Stat3 protein, rat
  • Tumor Necrosis Factor-alpha
  • Insulin-Like Growth Factor II
  • Mitogen-Activated Protein Kinase 7
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 5
  • Map2k5 protein, rat